Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Nasal Spray for Recurrent Acute Rhinosinusitis
NCT06264141Phase 2Completed
- Sponsor
- SaNOtize
- Start
- Jan 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in recurrent acute rhinosinusitis (RARS), sponsored by SaNOtize. Started Jan 2024; status: completed.
02
Drugs
Nitric oxide patch (Fundación Cardiovascular de Colombia)
03
Conditions
recurrent acute rhinosinusitis (RARS)
Beyond the preview
Go deeper on NCT06264141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06264141.